Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

Merida’s therapeutics also aim to deplete the B cells responsible for producing the harmful antibodies. Merida’s lead programme will focus on Graves’ disease, an autoimmune condition that causes the ...

Treatment options include antithyroid drugs (ATD), surgery, and radioactive iodine ablation (RI). Although thyroid peroxidase antibodies (anti-TPO) are prevalent in patients with GD, their role in ...

IgE is the antibody responsible for allergic reactions, such as hives or rash. Autoimmunity is thought to be one of the most common causes of chronic hives. Not all autoimmune diseases trigger an IgE ...

Attribution (BY): Credit must be given to the creator. Immunoreagents, most commonly antibodies, are integral components of lateral flow immunoassays. However, the use of antibodies comes with ...

The variable domain gene usage was diverse in these monoclonal antibodies. SAN DIEGO — An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha ...

The taller-than-wide sonographic feature did not demonstrate sufficient ability to differentiate between malignant and benign thyroid nodules. The taller-than-wide (TTW) thyroid nodule feature has ...

antibody) for the treatment of thyroid eye disease (TED). As China's first and the world's second approved IGF-1R antibody drug, SYCUME® has ended a 70-year drought of no new treatment option ...

AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a ...

View Full Profile. Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are ...